Defatting of donor transplant livers during normothermic perfusion—a randomised clinical trial: study protocol for the DeFat study

Syed Hussain Abbas,Carlo D. L. Ceresa,Leanne Hodson,David Nasralla,Christopher J. E. Watson,Hynek Mergental,Constantin Coussios,Fotini Kaloyirou,Kerrie Brusby,Ana Mora,Helen Thomas,Daphne Kounali,Katie Keen,Joerg-Matthias Pollok,Rohit Gaurav,Satheesh Iype,Wayel Jassem,M. Thamara PR Perera,Abdul Rahman Hakeem,Simon Knight,Peter J. Friend

DOI: https://doi.org/10.1186/s13063-024-08189-4

IF: 2.728

2024-06-19

Trials

Abstract:Liver disease is the third leading cause of premature death in the UK. Transplantation is the only successful treatment for end-stage liver disease but is limited by a shortage of suitable donor organs. As a result, up to 20% of patients on liver transplant waiting lists die before receiving a transplant. A third of donated livers are not suitable for transplant, often due to steatosis. Hepatic steatosis, which affects 33% of the UK population, is strongly associated with obesity, an increasing problem in the potential donor pool. We have recently tested defatting interventions during normothermic machine perfusion (NMP) in discarded steatotic human livers that were not transplanted. A combination of therapies including forskolin (NKH477) and L-carnitine to defat liver cells and lipoprotein apheresis filtration were investigated. These interventions resulted in functional improvement during perfusion and reduced the intrahepatocellular triglyceride (IHTG) content. We hypothesise that defatting during NMP will allow more steatotic livers to be transplanted with improved outcomes.

medicine, research & experimental

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to optimize the quality of fatty liver donor livers through lipid - removal interventions during normothermic machine perfusion (NMP) to make them suitable for transplantation, thereby increasing the success rate of transplantation and reducing the mortality rate of patients waiting for transplantation. Specifically, the research focuses on the following aspects:

1. **Increasing the utilization rate of fatty liver**: Since fatty liver (especially severe fatty liver) is prone to ischemia - reperfusion injury (IRI) after transplantation, increasing the risk of transplantation failure, many fatty livers are discarded. The research hopes that through lipid - removal interventions, these fatty livers can meet the transplantation criteria, thereby increasing the number of available donor organs.

2. **Evaluating the safety and feasibility of lipid - removal interventions**: The research designed a multi - center randomized clinical trial, randomly assigning 60 high - risk fatty livers to the NMP group or the NMP plus lipid - removal intervention group to evaluate the safety and feasibility of lipid - removal interventions.

3. **Exploring the effectiveness of lipid - removal interventions**: By comparing the liver functions between the two groups after ex - vivo and reperfusion, the research aims to verify whether lipid - removal interventions can effectively improve the function of fatty liver and reduce the risk of postoperative complications.

4. **Determining the primary endpoint indicators**: The primary endpoint is the proportion of livers that reach predefined functional criteria during perfusion, which reflect the liver's metabolism and injury situation, including lactate clearance, perfusate pH value, glucose metabolism, bile composition, vascular flow and transaminase levels.

5. **Evaluating clinical secondary endpoints**: Secondary endpoints include the proportion of livers actually transplanted in the two groups, graft function, cell - free DNA (cfDNA) follow - up, patient and graft survival rates, hospitalization and intensive care unit (ITU) stay time, evidence of ischemia - reperfusion injury, non - anastomotic biliary stricture and recurrence of fatty liver determined by MRI at 6 months.

Through these research objectives, the authors hope to prove the effectiveness of lipid - removal interventions during NMP, thereby providing a scientific basis for clinical applications and ultimately reducing the mortality rate of patients waiting for transplantation due to insufficient donor organs.